Treatment of human endothelial cells with cytokines such as tumour necrosis factor-α
(TNF) or E. coli lipopolysaccharide (LPS) induces the expression of several adhesion molecules and
enhances leukocyte adhesion to endothelial cell surface. Interfering with this leukocyte
adhesion or adhesion molecules upregulation is an important therapeutic target for
the treatment of bacterial sepsis and various inflammatory diseases. In the course
of screening marketed European anti-inflammatory herbal drugs for TNF antagonistic
activity, a crude ethanolic extract of corn silk (stigma of Zea mays) exhibited significant activity. The extract at concentrations of 9-250 µg/ml effectively
inhibited the TNF- and LPS-induced adhesiveness of EAhy 926 endothelial cells to monocytic
U937 cells. Similar concentration ranges of corn silk extract did also block the TNF
and LPS but not the phorbol 12-myristate 13-acetate-induced ICAM-1 expression on EAhy
926 endothelial cell surface. The extract did not alter the production of TNF by LPS-activated
macro-phages and failed to inhibit the cytotoxic activity of TNF. It is concluded
that corn silk possesses important therapeutic potential for TNF- and LPS-mediated
leukocyte adhesion and trafficking.
Corn silk -
Zea mays
- Gramineae - TNF - LPS - PMA - adhesion - ICAM-1